Original Investigation

Intracranial Hemorrhage in Patients With Stroke After Endovascular Treatment With or Without IV Alteplase

JAMA Neurology 10.1001/jamaneurol.2025.2610

August 11, 2025 at 11:00 AM EDT

Read the full article

What is the profile of intracranial hemorrhage (ICH) in patients with stroke after endovascular treatment with or without intravenous alteplase, and what is the association with patient outcomes?In this individual participant data meta-analysis (n = 2313 participants) of 6 randomized clinical trials, intravenous thrombolysis before thrombectomy was associated with a significant increase of any ICH (36% vs 32%) and parenchymal hematoma (7% vs 5%) vs thrombectomy alone. Asymptomatic and symptomatic ICH were both associated with worse functional outcomes.Intravenous thrombolysis before thrombectomy may modestly increase the risk of ICH (notably, any parenchymal hematoma), but this effect may be offset by its benefit in reperfusion.

Corresponding Authors: Pengfei Yang, MD (p.yang@vip.163.com), and Jianmin Liu, MD (liu118@vip.163.com), Neurovascular Center, Naval Medical University Changhai Hospital, 168 Changhai Road, Shanghai, China.

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

https://jamanetwork.com/journals/jamaneurology/fullarticle/10.1001/jamaneurol.2025.2610?utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_term=081125

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks